BioSpace News Archive

The healthcare category research depicts a clear overview of various inter-connected factors that can influence the development of global gamma probe device market in coming years.

Clopidogrel is an antiplatelet agent of thienopyridine, which is primarily used to prevent the blood clots and help against cardiovascular problems associated with the blood clotting.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced that Luciana Borio, M.D., has been appointed to the Company’s Board of Directors.

Omeros Corporation announced that the company received a Complete Response Letter from the U.S. Food and Drug Administration regarding its Biologics License Application for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the appointment of Young T. Kwon, Ph.D., to its Board of Directors.

Kura Oncology, Inc. today announced the appointment of Teresa Bair as Chief Legal Officer and Corporate Secretary.

U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy ® for Treatment of HIV-1 in Pediatric Populations

Saniona (OMX: SANION), today announced that it has completed the submission of all information previously requested by the U.S. Food and Drug Administration (FDA) regarding its chemistry, manufacturing and controls (CMC) program for Tesomet capsules.

Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced two poster presentations at AASLD’s Liver Meeting® 2021 showcasing clinical data for VTP-300, the Company’s immunotherapeutic in development for the treatment of chronic hepatitis B virus (HBV) infection.

Among the many health challenges facing children is the very real threat of contracting Lyme disease as nearly 30% of the estimated 476,000 people in the U.S. each year who are diagnosed and treated for this disease are ages 0-19. In response to this troubling fact, an important webinar focused on how Lyme disease affects the pediatric population will be held on Thursday, Oct. 21.